Novo Nordisk to Invest DKK 8.5 Billion to New Manufacturing Plant in Odense, Denmark

Specifications:

Name:

Novo Nordisk to Invest DKK 8.5 Billion to New Manufacturing Plant in Odense, Denmark

Location:

Odense, Denmark

Company:

Novo Nordisk

Estimated Cost:

DKK 8.5 Billion

Source:

https://www.novonordisk.com/

Introduction:

Novo Nordisk has unveiled plans to invest 8.5 billion Danish kroner in a groundbreaking production plant in Odense, Denmark.

Features:

The upcoming plant will encompass a cutting-edge production facility and warehouse, covering over 40,000 m². Designed with modularity and flexibility in mind, it will support the manufacturing of various rare disease treatments, including those for haemophilia, both now and in the future.

Advanced technology and innovative equipment will be employed to ensure top-quality medicines for patients while meeting the increasing global demand for life-changing treatments.

In alignment with its commitment to environmental preservation, Novo Nordisk plans to plant more than 4,000 trees on the site to safeguard the natural surroundings.

This investment is projected to generate 400 permanent jobs once the plant is operational, with up to 1,000 external workers engaged during the construction phase.

Construction has already begun, with completion anticipated in 2027.